← Back to Patent Explorer
US4713324A Expired / Lapsed US ⏱️ 0.0 years remaining

Inverted latency specific binding assay

Assignee: Bayer Corp
•
Filing: 1983-09-01
•
Granted: 1987-12-15
•
Expires: 2003-09-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A specific binding assay composition and method for determining a ligand in a sample are disclosed. The composition comprises (a) a binding partner for the ligand; (b) a detection system which has at least two components; (c) a selectively accessible vesicle having a surface-incorporated ligand or ligand analog and a first component of the detection system therein; (d) a substance which modifies vesicle accessibility in response to binding of surface-associated ligand or ligand analog and binding partner; and (e) at least one additional component of the detection system which is reactive with the first component to produce a detectable response which is reduced by association of the binding partner and vesicle modifying substance with the variabily accessible vesicle. A decrease in signal is measured upon reaction as compared to the signal of unreacted vesicles.

Inventors

  • 👤 John P. Fox
  • 👤 Eddie Hedaya
  • 👤 Violet Lippman

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 14:49
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/554; G01N33/536; G01N33/542; Y; Y10; Y10S; Y10S435/00; Y10S435/966; Y10S435/968; Y10S436/00; Y10S436/829

Claims Analysis

Total Claims: 25
Claim 1
Independent Claim 113 words
A composition for determining a ligand in a sample, which composition comprises: (a) a binding partner for said ligand; (b) a detection system which has at least two components; (c) a selective permeable vesicle having a surface bound ligand or ligand analog and a first component of said detection system therein; (d) a substance which modifies vesicle permeability in response to binding of surface-bound ligand or ligand analog and the binding partner; and (e) at least an additional component of said detection system which is reactive with said first component to produce a detectable response which is reduced when the vesicle is in the presence of the binding partner and vesicle modifying substance.
Claim 2
Dependent Claim 113 words
A composition for determining a ligand in a sample, which composition comprises: (a) a binding partner for said ligand; (b) a detection system which has at least two components; (c) a selective permeable vesicle having a surface bound ligand or ligand analog and a first component of said detection system therein; (d) a substance which modifies vesicle permeability in response to binding of surface-bound ligand or ligand analog and the binding partner; and (e) at least an additional component of said detection system which is reactive with said first component to produce a detectable response which is reduced when the vesicle is in the presence of the binding partner and vesicle modifying substance.
Claim 3
Dependent Claim 14 words
The composition of claim 1 wherein the vesicle is comprised of a lipid membrane.
Claim 4
Dependent Claim 12 words
The composition of claim 2 wherein the lipid membrane comprises a phospholipid.
Claim 5
Dependent Claim 12 words
The composition of claim 2 wherein the lipid membrane incorporates a sterol.
Claim 6
Dependent Claim 21 words
The composition of claim 2 wherein the lipid membrane includes an amphiphile to which the ligand or ligand analog is bound.
Claim 7
Dependent Claim 13 words
The composition of claim 1 wherein the vesicle is a biological cell membrane.
Claim 8
Dependent Claim 25 words
The composition of claim 1 wherein the first component of the detection system comprises a peroxidatively active substance and the additional component comprises a luminophore.
Claim 9
Dependent Claim 12 words
The composition of claim 7 wherein the peroxidatively active substance comprises peroxidase.
Claim 10
Dependent Claim 22 words
The composition of claim 7 further comprising an oxidant for the luminophore, which oxidant is a substrate for the peroxidatively active substance.
Claim 11
Dependent Claim 11 words
The composition of claim 9 wherein the oxidant is hydrogen peroxide.
Claim 12
Dependent Claim 18 words
The composition of claim 7 further comprising an enzymatic system effective to produce an oxidant for the luminophore.
Claim 13
Dependent Claim 14 words
The composition of claim 11 wherein the enzymatic system comprises glucose oxidase and glucose.
Claim 14
Dependent Claim 15 words
The composition of claim 1 wherein the detection system further comprises an energy transfer system.
Claim 15
Dependent Claim 36 words
The composition of claim 11 wherein the detection system comprises a luminophore and an energy transfer system including a fluor which absorbs light energy at the wavelength of the luminophore and fluoresces at a different wavelength.
Claim 16
Dependent Claim 25 words
The composition of claim 1 which comprises an additional substance which further diminishes the luminescence of said detection system upon the increase of vesicle permeability.
Claim 17
Dependent Claim 11 words
The composition of claim 15 wherein the additional substance is cyanide.
Claim 18
Dependent Claim 21 words
The composition of claim 1 wherein the ligand is a hapten or antigen and the binding partner is an antibody therefor.
Claim 19
Dependent Claim 12 words
The composition of claim 1 wherein the vesicle modifying substance is complement.
Claim 20
Dependent Claim 59 words
A composition for determining a ligand in a sample, which composition comprises: (a) antibody for said ligand; (b) complement; (c) a luminophore; (d) hydrogen peroxide; and (e) a liposome having a ligand or ligand analog on the surface thereof and peroxidase therein, which liposome exhibits a detectable signal that is reduced upon being bound with said antibody and complement.
Claim 21
Dependent Claim 59 words
A composition for determining a ligand in a sample, which composition comprises: (a) antibody for said ligand; (b) complement; (c) a luminophore; (d) hydrogen peroxide; and (e) a liposome having a ligand or ligand analog on the surface thereof and peroxidase therein, which liposome exhibits a detectable signal that is reduced upon being bound with said antibody and complement.
Claim 22
Independent Claim 98 words
A method for determining the presence and amount of a ligand in a sample, which method comprises the steps of: (a) combining said sample and the composition of any of claims 1, 2, 7-10, 13 or 15-19 to form a reaction mixture; (b) measuring the reduction of a detectable response of said reaction mixture; and (c) comparing the detectable response conducted in the presence of said sample with the response conducted in the presence of a series of standard compositions containing known amounts of ligand as an indication of the presence and amount of ligand in the sample.
Claim 23
Dependent Claim 57 words
A composition for a detection system comprising: (a) a selectively permeable vesicle; (b) a first component of said detection system within said vesicle; and (c) at least one additional component of said detection system which is reactive with said first component to produce a detectable response which is reduced by an increase in permeability of said vesicle.
Claim 24
Dependent Claim 57 words
A composition for a detection system comprising: (a) a selectively permeable vesicle; (b) a first component of said detection system within said vesicle; and (c) at least one additional component of said detection system which is reactive with said first component to produce a detectable response which is reduced by an increase in permeability of said vesicle.
Claim 25
Dependent Claim 25 words
The composition of claim 21 which comprises an additional substance which further diminishes the luminescence of said detection system upon the increase of vesicle permeability.

References Cited (Backward Citations)

US4174384A Cited
US4134792A Cited
US4235792A Cited
US4220450A Cited
US4193983A Cited
US4372745A Cited
US4342826A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-12-14 1991-06-15 1991-12-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-12-14 1995-06-15 1995-12-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-12-14 1999-06-15 1999-12-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag